BRIEF published on 10/03/2024 at 14:41, 1 month 19 days ago Dalata Hotel Group PLC: Major Voting Rights Change by JPMorgan Chase & Co. Acquisition Voting Rights Dalata Hotel Group Equity Swap JPMorgan Chase & Co.
PRESS RELEASE published on 10/03/2024 at 14:36, 1 month 19 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* JPMorgan Chase & Co. notifies major holdings in Dalata Hotel Group PLC, crossing 3% threshold on 30-Sep-2024 Major Holdings Notification Dalata Hotel Group 3% Threshold JPMorgan Chase
BRIEF published on 10/03/2024 at 10:48, 1 month 19 days ago UBS Increases Financial Instruments Holding in Dalata Hotel Group Voting Rights Investment Banking Financial Instruments Dalata Hotel Group UBS Group AG
PRESS RELEASE published on 10/03/2024 at 10:43, 1 month 19 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* UBS Investment Bank & Wealth Management discloses 3.30% voting rights in Dalata Hotel Group PLC as of 27th September 2024 Voting Rights Wealth Management Dalata Hotel Group Plc Notification Of Major Holdings UBS Investment Bank
BRIEF published on 10/03/2024 at 10:29, 1 month 19 days ago Dalata Hotel Group PLC Announces Total Voting Rights Shareholders London Stock Exchange Euronext Dublin Total Voting Rights Dalata Hotel Group
PRESS RELEASE published on 10/03/2024 at 10:24, 1 month 19 days ago Dalata Hotel Group PLC: TVR-Total Voting Rights Dalata Hotel Group PLC announces total voting rights of 219,293,352 Ordinary Shares as of 3rd October 2024, in compliance with Transparency Regulations Shareholders Revenue Total Voting Rights Dalata Hotel Group Transparency Regulations
BRIEF published on 10/03/2024 at 08:05, 1 month 19 days ago Dalata Hotel Group Executes Share Buyback Shareholders Share Buyback Euronext Dublin Ireland Dalata Hotel Group
PRESS RELEASE published on 10/03/2024 at 08:00, 1 month 19 days ago Dalata Hotel Group PLC: POS-Transaction in Own Shares Dalata Hotel Group PLC purchases 100,555 of its ordinary shares, cancelling them, following a share buyback program. Total voting rights to be 219,293,352 Voting Rights Ordinary Shares Share Buyback Program Euronext Dublin Dalata Hotel Group Plc
BRIEF published on 10/02/2024 at 08:05, 1 month 20 days ago Dalata Hotel Group PLC Purchases Own Shares Ordinary Shares Share Buyback Euronext Dublin Capital Optimization Dalata
PRESS RELEASE published on 10/02/2024 at 08:00, 1 month 20 days ago Dalata Hotel Group PLC: POS-Transaction in Own Shares Dalata Hotel Group PLC announces the purchase of 229,975 ordinary shares at prices between €4.06 and €4.15 as part of the Share Buyback Programme Ordinary Shares Share Buyback Euronext Dublin Purchase Dalata Hotel Group
Published on 11/22/2024 at 14:45, 16 minutes ago Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 14:30, 31 minutes ago Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best
Published on 11/22/2024 at 14:20, 41 minutes ago Plaintree Systems Inc. Announces Second Quarter Fiscal 2025 Results
Published on 11/22/2024 at 14:00, 1 hour 1 minute ago Clear Start Tax Warns Taxpayers About Upcoming IRS Collection Changes in 2025
Published on 11/22/2024 at 14:46, 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/22/2024 at 14:44, 16 minutes ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Published on 11/22/2024 at 14:43, 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Published on 11/22/2024 at 14:42, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Published on 11/21/2024 at 06:58, 1 day 8 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 19 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 21 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 21 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
